Patents by Inventor William Charles Vogt

William Charles Vogt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190013090
    Abstract: The present invention is generally directed to methods and devices for determining dosing for a medical agent. In some embodiments, a mathematical algorithm is employed for computing erythropoiesis-stimulating agents dosing for treating anemia in a subject, e.g., a human subject. Any suitable dosing may be used, e.g., intravenous, subcutaneous, or oral dosing. In some cases, dosing for a wide range of subject types and health conditions can be achieved using the devices and methods disclosed herein.
    Type: Application
    Filed: July 11, 2018
    Publication date: January 10, 2019
    Applicants: University of Massachusetts, Analiza, Inc.
    Inventors: Yossi Chait, Michael J. Germain, Christopher V. Hollot, Joseph Horowitz, William Charles Vogt
  • Patent number: 10049187
    Abstract: The present invention is generally directed to methods and devices for determining dosing for a medical agent. In some embodiments, a mathematical algorithm is employed for computing erythropoiesis-stimulating agents dosing for treating anemia in a subject, e.g., a human subject. Any suitable dosing may be used, e.g., intravenous, subcutaneous, or oral dosing. In some cases, dosing for a wide range of subject types and health conditions can be achieved using the devices and methods disclosed herein.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: August 14, 2018
    Assignees: University of Massachusetts, Analiza, Inc.
    Inventors: Yossi Chait, Michael J. Germain, Christopher V. Hollot, Joseph Horowitz, William Charles Vogt
  • Publication number: 20150220700
    Abstract: The present invention is generally directed to methods and devices for determining dosing for a medical agent. In some embodiments, a mathematical algorithm is employed for computing erythropoiesis-stimulating agents dosing for treating anemia in a subject, e.g., a human subject. Any suitable dosing may be used, e.g., intravenous, subcutaneous, or oral dosing. In some cases, dosing for a wide range of subject types and health conditions can be achieved using the devices and methods disclosed herein.
    Type: Application
    Filed: September 12, 2013
    Publication date: August 6, 2015
    Applicants: UNIVERSITY OF MASSACHUSETTS, ANALIZA, INC.
    Inventors: Yossi Chait, Michael J. Germain, Christopher V. Hollot, Joseph Horowitz, William Charles Vogt